Undiagnosed Cryptococcus gattii meningitis leading to subsequent ventriculoperitoneal shunt infection in a patient with symptoms of normal pressure hydrocephalus: case report and literature review
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Undiagnosed Cryptococcus gattii meningitis leading to subsequent ventriculoperitoneal shunt infection in a patient with symptoms of normal pressure hydrocephalus: case report and literature review
Authors
Keywords
-
Journal
BMC INFECTIOUS DISEASES
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-06-04
DOI
10.1186/s12879-018-3165-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa
- (2018) Síle F. Molloy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cryptococcal Infection of the Ventriculoperitoneal Shunt in an HIV-Infected Patient with an Excellent Immunovirologic Status
- (2017) Miguel Genebat et al. World Neurosurgery
- Disseminated Cryptococcosis Due to Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Absence of Pulmonary Alveolar Proteinosis
- (2016) Chen-Yen Kuo et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Cryptococcal meningitis complicated with a large abdominal cyst mimicking acute pancreatitis
- (2016) Chih-Hsun Lee et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Human leukocyte antigen and risk of disseminated histoplasmosis in solid organ transplant recipients
- (2016) A. Zimmer et al. Transplant Infectious Disease
- Cryptococcus gattii Infections
- (2014) Sharon C.-A. Chen et al. CLINICAL MICROBIOLOGY REVIEWS
- Cryptococcal ventriculoperitoneal shunt infection
- (2014) Matthew J. Viereck et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies Are a Risk Factor for Central Nervous System Infection by Cryptococcus gattii in Otherwise Immunocompetent Patients
- (2014) T. Saijo et al. mBio
- Anti-GM-CSF Autoantibodies in Patients with Cryptococcal Meningitis
- (2013) L. B. Rosen et al. JOURNAL OF IMMUNOLOGY
- Molecular Epidemiology Reveals Genetic Diversity amongst Isolates of the Cryptococcus neoformans/C. gattii Species Complex in Thailand
- (2013) Sirada Kaocharoen et al. PLoS Neglected Tropical Diseases
- Dynamic Interaction between Fluconazole and Amphotericin B against Cryptococcus gattii
- (2012) Julliana Ribeiro Alves Santos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole
- (2012) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adult-Onset Immunodeficiency in Thailand and Taiwan
- (2012) Sarah K. Browne et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
- (2010) John R. Perfect et al. CLINICAL INFECTIOUS DISEASES
- Global VGIIa isolates are of comparable virulence to the major fatal Cryptococcus gattii Vancouver Island outbreak genotype
- (2010) P. Ngamskulrungroj et al. CLINICAL MICROBIOLOGY AND INFECTION
- A Phase II Randomized Trial of Amphotericin B Alone or Combined with Fluconazole in the Treatment of HIV‐Associated Cryptococcal Meningitis
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Case Report: Cryptococcal Meningitis Manifesting as a Large Abdominal Cyst in a HIV-Infected Patient with a CD4 Count Greater than 400 cells/mm3
- (2008) Nancy Crum-Cianflone et al. AIDS PATIENT CARE AND STDS
- Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans
- (2008) G. R. Thompson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started